FCPM III SERVICES B.V.
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | ENGN | 9.63M | $65.60M |
 | NAMS | 9.20M | $294.46M |
 | DYN | 4.64M | $84.20M |
 | VOR | 4.12M | $73.45M |
 | BCYC | 3.47M | $16.09M |
 | MPLT | 3.23M | $65.59M |
 | REPL | 2.81M | $21.48M |
 | DMRA | 2.44M | $63.22M |
 | CBIO | 1.68M | $30.82M |
enGene Holdings Inc.
ENGN
Shares Held
9.63M
Value
$65.60M
NewAmsterdam Pharma Company N.V.
NAMS
Shares Held
9.20M
Value
$294.46M
Dyne Therapeutics, Inc.
DYN
Shares Held
4.64M
Value
$84.20M
Vor Biopharma Inc.
VOR
Shares Held
4.12M
Value
$73.45M
Bicycle Therapeutics plc
BCYC
Shares Held
3.47M
Value
$16.09M
MapLight Therapeutics, Inc.
MPLT
Shares Held
3.23M
Value
$65.59M
Replimune Group, Inc.
REPL
Shares Held
2.81M
Value
$21.48M
Galecto, Inc.
DMRA
Shares Held
2.44M
Value
$63.22M
Crescent Biopharma, Inc.
CBIO
Shares Held
1.68M
Value
$30.82M